Deadpool

Blend containing 10 mg Cartalax, 5 mg TB-500 and 5 mg BPC-157

Deadpool — 20 mg Vial

Certificate of Analysis

View COA
Choose format

€35

In stock

Recommended accessories

Reusable Pen€25

In stock

Product information

Deadpool brings together Cartalax, TB-500 and BPC-157. Cartalax has limited research specific to the peptide, while work on the other two cannot establish what this blend does.

What sets Cartalax apart?

Cartalax is a short peptide discussed in cartilage-related exploratory research. BPC-157 is studied in cell-movement models; the TB-500 name may refer to thymosin-beta-4-related sequences, so the exact sequence matters.

Storage & preparation

Before mixing
Store the sealed freeze-dried blend cool, dry and protected from light. Follow the batch documentation for any temperature-specific requirements.
After mixing
Keep refrigerated and protected from light; record preparation date and use a laboratory-validated stability procedure for the mixture.
Preparing the vial
Supplied as a freeze-dried research blend. If a laboratory protocol calls for reconstitution, confirm solvent compatibility with all three components, handle gently and follow the protocol and batch documentation. No universal dilution volume or prepared-blend shelf life is specified.

Unreconstituted three-component blend; verify solvent compatibility with all components before laboratory preparation.

Frequently asked questions

Which ingredient matches each listed strength?

Check the batch label for the mapping of the three amounts to Cartalax, TB-500 and BPC-157; the three figures alone do not identify which is which.

For research use only.

Our products are supplied for laboratory and in-vitro research and are not intended for human or veterinary use. By ordering, you confirm you're a qualified researcher and will handle the material responsibly.